US health..spending increased 5.8%..3.2 Trillion which is also expected to impel the growth of stem Cell and regenerative medicine market in the North America. U.S. is the prominent market driving the growth in the region.
..North America is slated to account for a leading share of 39.7% by 2024 in the stem cell and regenerative medicine market. The growth in the region can be attributed to presence of well-established healthcare industry along with expanded funding from the governments organizations.
..The $10 billion healthcare specialist fund run by Felix and Julian Baker, Baker Bros. Advisors, is no stranger to taking out big positions in small companies, and this strategy has paid off handsomely. Over the last nine quarters, for example, the fund has grown by a jaw-dropping 256%.
Recent 13Fs filed with the SEC showed Baker Bros. opened a massive position in the clinical-stage biopharma Bellicum Pharmaceuticals (NASDAQ:BLCM)
..specifically, the company is tackling immunotherapies such as hematopoietic stem cell transplantation
$LAHO NOT TO SOUND Overtly prescriptive BUT WHY SELL WHEN MONEY IS POURING IN STEM CELL COMPANIES LARGE AND SMALL?? TRILLION DOLLAR HEALTH CARE INDUSTRY..BILLIONAIRES POURING MONEY IN..HEDGE FUNDS LINGING UP..GSCG$$$
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.